ARTICLE | Clinical News
Affymax N.V. regulatory update
January 3, 1994 8:00 AM UTC
AFMXF (Palo Alto) received a U.S. patent on its peptides and plasmids technology. Patent No. 5,270,170 covers a technique for generating and screening large libraries of random peptides. AFMXF said the technique is useful for finding peptide ligands for a variety of biological receptors. ...